143 related articles for article (PubMed ID: 25023636)
1. In vitro activity of new cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008-2011.
Green K; McGeer A; Rudnick W; Pong-Porter S; Patel SN; Low DE;
Curr Microbiol; 2014 Nov; 69(5):763-7. PubMed ID: 25023636
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers.
Flamm RK; Sader HS; Farrell DJ; Jones RN
Antimicrob Agents Chemother; 2014; 58(4):2468-71. PubMed ID: 24514082
[TBL] [Abstract][Full Text] [Related]
3. Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate.
Pfaller MA; Mendes RE; Flamm RK; Jones RN; Sader HS
Microb Drug Resist; 2017 Jul; 23(5):571-579. PubMed ID: 27918694
[TBL] [Abstract][Full Text] [Related]
4. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
Pfaller MA; Farrell DJ; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
McGee L; Biek D; Ge Y; Klugman M; du Plessis M; Smith AM; Beall B; Whitney CG; Klugman KP
Antimicrob Agents Chemother; 2009 Feb; 53(2):552-6. PubMed ID: 19015339
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
Zhanel GG; Yachison C; Nichol K; Adam H; Noreddin AM; Hoban DJ; Karlowsky JA
J Antimicrob Chemother; 2012 Jul; 67(7):1706-11. PubMed ID: 22467630
[TBL] [Abstract][Full Text] [Related]
8. Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Jacobs MR; Good CE; Windau AR; Bajaksouzian S; Biek D; Critchley IA; Sader HS; Jones RN
Antimicrob Agents Chemother; 2010 Jun; 54(6):2716-9. PubMed ID: 20308374
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance profile and multidrug resistance patterns of Streptococcus pneumoniae isolates from patients suspected of pneumococcal infections in Ethiopia.
Sharew B; Moges F; Yismaw G; Abebe W; Fentaw S; Vestrheim D; Tessema B
Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):26. PubMed ID: 33879172
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
Sader HS; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208
[TBL] [Abstract][Full Text] [Related]
11. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
[TBL] [Abstract][Full Text] [Related]
12. Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014).
Pfaller MA; Rhomberg PR; Huband MD; Flamm RK
Diagn Microbiol Infect Dis; 2018 Feb; 90(2):143-147. PubMed ID: 29157954
[TBL] [Abstract][Full Text] [Related]
13. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission.
Samore MH; Magill MK; Alder SC; Severina E; Morrison-De Boer L; Lyon JL; Carroll K; Leary J; Stone MB; Bradford D; Reading J; Tomasz A; Sande MA
Pediatrics; 2001 Oct; 108(4):856-65. PubMed ID: 11581436
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
Fenoll A; Aguilar L; Robledo O; Giménez MJ; Granizo JJ; Biek D; Tarragó D
Antimicrob Agents Chemother; 2008 Nov; 52(11):4209-10. PubMed ID: 18725443
[No Abstract] [Full Text] [Related]
15. Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011).
Jones RN; Sader HS; Mendes RE; Flamm RK
Diagn Microbiol Infect Dis; 2013 Jan; 75(1):107-9. PubMed ID: 23009730
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005.
Thornsberry C; Brown NP; Draghi DC; Evangelista AT; Yee YC; Sahm DF
Postgrad Med; 2008 Sep; 120(3 Suppl 1):32-8. PubMed ID: 18931469
[TBL] [Abstract][Full Text] [Related]
17. Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Castanheira M; Gales AC; Pignatari AC; Jones RN; Sader HS
Microb Drug Resist; 2006; 12(2):91-8. PubMed ID: 16922623
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance of invasive Streptococcus pneumoniae in Slovenia, 1993-1995. The Slovenian Meningitis Study Group.
Cizman M; Paragi M; Jovan-Kuhar N; Gubina M; Orazem A; Pokorn M
Scand J Infect Dis; 1997; 29(3):251-4. PubMed ID: 9255884
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents.
Pottumarthy S; Fritsche TR; Sader HS; Stilwell MG; Jones RN
Int J Antimicrob Agents; 2005 Apr; 25(4):282-9. PubMed ID: 15784306
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
Zhanel GG; Palatnick L; Nichol KA; Bellyou T; Low DE; Hoban DJ
Antimicrob Agents Chemother; 2003 Jun; 47(6):1867-74. PubMed ID: 12760860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
